Accelerating Scientific Research Using the Cloud
The “cloud lab” is a virtual laboratory setting that can enable scientists to more quickly advance research.
Determining Efficacy and Proper Methodology in Cleanroom Cleaning
It is vital to consider optimal cleaning and disinfection practices when operating a cleanroom.
Standard BioTools Launches Hyperion+ Imaging System
Standard BioTools’ new Hyperion+ Imaging System can process more samples and has lower limits of detection than their current product.
FDA Grants Quanterix Plasma Test Breakthrough Device Designation
FDA granted Quanterix’s neurofilament light chain plasma test a breakthrough device designation as a prognostic aid for relapsing-remitting multiple sclerosis.
Accelerate Diagnostics Blood Culture Kit Demonstrates Increased Efficacy
Accelerate Diagnostics’ new blood culture kit demonstrated 94% or greater accuracy on positive blood cultures relative to matrix-assisted laser desorption/ionization (MALDI).
Bio-Rad’s Three New Fluorescent Dyes are Intended to Enhance Multiplex Flow Cytometry
Bio-Rad Laboratories introduces three new fluorescent dyes under the StarBright product range to support multicolor flow cytometry panels.
Arrayjet Launches New Range of Next-Generation Microarray Printers
A new range of five instruments for ultra-low-volume liquid dispensing for microarray and microfluidics applications, Mercury, has been introduced by Arrayjet.
CN Bio Launches PhysioMimix, an “In-a-Box” Reagent Kit for NASH
CN Bio’s PhysioMimix “in-a-box” reagent kit is designed to harness liver-on-a-chip technology to improve accuracy and efficiency in drug discovery.
AmoyDX and AstraZeneca Enter Master Collaboration Agreement
AmoyDX has entered a Master Collaboration Agreement with AstraZeneca for multiple companion diagnostics programs in China, EU, and Japan.
VectorBuilder to Expand with $500 Million Gene Delivery Research and Manufacturing Campus
VectorBuilder will expand with the construction of new $500 million Gene Delivery Research and Manufacturing Campus in Guangzhou, China.
University Hospital Hamburg-Eppendorf Leads Trial to Explore Personalized Medicine in COVID-19
Biomarker-guided trial led by University Hospital Hamburg-Eppendorf (UKE) opens new avenues for personalized medicine for treatment of COVID-19.
Ymmunobio AG Signs Patent Purchase Agreement with LeukoCom GmbH
Ymmunobio AG has signed a patent purchase agreement with LeukoCom GmbH to expand its development of cancer therapies.
